London Research & Pharmaceuticals is an independent biopharmaceutical research and development brand specializing in the discovery of proprietary new drugs and candidates. With 250 years of combined research experience, the brand is dedicated to developing medications that offer improved efficacy and reduced toxicity compared to current treatment options. They have completed multiple pre-clinical trials and have a diverse pharmaceutical pipeline with strong efficacy and low toxicity. Their research covers various therapeutic areas, including epilepsy, pain inflammation, PTSD/anxiety, infectious disease, psychiatric disorders, inflammatory bowel syndrome, and oncology.

The brand prides itself on its leadership and advisory expertise, which includes global pharmaceutical development, large pharma executive experience, regulatory knowledge (FDA, EMA), and a strong financial and strategic background. The team at London Research & Pharmaceuticals consists of experts in organic and medicinal chemistry, chemical engineering, formulation science, medical biophysics, anesthesia, pain pharmacology, and pharmD. They also have extensive experience in clinical trials and addressable markets such as neurological conditions, anti-inflammatory, analgesics, antibacterial, oncology, mental health, and health & wellness. For more information or inquiries, you can contact London Research & Pharmaceuticals at the Western University Discovery Park in London, Canada.